Capital-infusions was established in United State in 2006 as a provider of online CFD trading services. Our client’s trading journey is very important to us, and as such we are always committed in refining our technology, tailored services and client education. For over a decade, as the industry and clients’ expectations keep evolving, we have positioned ourselves firmly as a trusted and leading United State regulated broker.
Capital-infusions currently offers a spread-based and a commission-based trading account. We have more than 350 tradeable CFD instruments including Forex, Shares, Indices and Commodities. Widely recognised as the first MT4 broker in Australia, we have since added MT5, mobile trading and a web-based platform to our suite of trading platforms.
We strive to be the first choice for trading CFDs for aspiring and experienced traders. We strive to continuously provide the best trading experience to our clients through reliable customer service, transparent pricing, low-latency trade execution and platform stability.
*Investment Trends December 2019 Australia Leverage Trading Report.
We strive to be the first choice for trading CFDs among aspiring and experienced traders, and continuously provide the best trading experience to our clients through reliable customer service, transparent pricing, low-latency trade execution and platform stability.
We endeavour to provide clients with transparent, secure and reliable services. Capital-infusions is licensed by the Australian Securities and Investment Commission (ASIC), AFSL 254963 and the Financial Services Commission (FSC) of Mauritius as an Investment Dealer (Discount Broker)
Capital-infusions is dedicated to ensuring fast execution speed, quality trading platforms and secure transactions as a minimum standard for your trading experience.